252 related articles for article (PubMed ID: 17085880)
1. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models.
Tsujimura K; Yamanaka T; Kondo T; Fukushi H; Matsumura T
J Vet Med Sci; 2006 Oct; 68(10):1029-38. PubMed ID: 17085880
[TBL] [Abstract][Full Text] [Related]
2. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
[TBL] [Abstract][Full Text] [Related]
4. Equine herpesvirus type 1 mutant defective in glycoprotein E gene as candidate vaccine strain.
TSUJIMURA K; SHIOSE T; YAMANAKA T; NEMOTO M; KONDO T; MATSUMURA T
J Vet Med Sci; 2009 Nov; 71(11):1439-48. PubMed ID: 19959893
[TBL] [Abstract][Full Text] [Related]
5. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
6. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
7. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
[TBL] [Abstract][Full Text] [Related]
8. Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model.
Frampton AR; Smith PM; Zhang Y; Matsumura T; Osterrieder N; O'Callaghan DJ
Virus Res; 2002 Dec; 90(1-2):287-301. PubMed ID: 12457983
[TBL] [Abstract][Full Text] [Related]
9. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
[TBL] [Abstract][Full Text] [Related]
10. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
11. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
[TBL] [Abstract][Full Text] [Related]
12. Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses.
Matsumura T; O'Callaghan DJ; Kondo T; Kamada M
Vet Microbiol; 1996 Feb; 48(3-4):353-65. PubMed ID: 9054131
[TBL] [Abstract][Full Text] [Related]
13. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
[TBL] [Abstract][Full Text] [Related]
14. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection.
Neubauer A; Beer M; Brandmüller C; Kaaden OR; Osterrieder N
Virology; 1997 Dec; 239(1):36-45. PubMed ID: 9426444
[TBL] [Abstract][Full Text] [Related]
15. A deletion in the gI and gE genes of equine herpesvirus type 4 reduces viral virulence in the natural host and affects virus transmission during cell-to-cell spread.
Damiani AM; Matsumura T; Yokoyama N; Mikami T; Takahashi E
Virus Res; 2000 Apr; 67(2):189-202. PubMed ID: 10867198
[TBL] [Abstract][Full Text] [Related]
16. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice.
Csellner H; Walker C; Wellington JE; McLure LE; Love DN; Whalley JM
Arch Virol; 2000; 145(11):2371-85. PubMed ID: 11205124
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the molecular detection of vaccine-derived equine herpesvirus type 1 in blood and nasal secretions from horses following intramuscular vaccination.
Pusterla N; Chaney KP; Maes R; Wise AG; Holland R; Schott HC
J Vet Diagn Invest; 2007 May; 19(3):290-3. PubMed ID: 17459860
[TBL] [Abstract][Full Text] [Related]
18. [Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation].
Neubauer A; Meindl A; Osterrieder N
Berl Munch Tierarztl Wochenschr; 1999 Sep; 112(9):351-4. PubMed ID: 10507185
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
[TBL] [Abstract][Full Text] [Related]
20. Growth of recombinant equine herpesvirus 1 (EHV-1) replaced with passage-induced mutant gene 1 and gene 71 derived from an attenuated EHV-1 in cell cultures and in the lungs of mice.
Kirisawa R; Kobayashi T; Uematsu R; Ikeda A; Kuroiwa R; Urakami A; Iwai H
Vet Microbiol; 2003 Sep; 95(3):159-74. PubMed ID: 12935744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
